Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel: +47 21 07 81 60
E-mail:

Copyright/Disclaimer

New DDDs

ATC code	ATC level name	New DDD

B02BX09	fostamatinib	0.2	g	O
B03XA05	roxadustat	43	mg	O
B06AC06	berotralstat	0.15	g	O
C01DX22	vericiguat	10	mg	O
C10AX15	bempedoic acid	0.18	g	O
C10AX16	inclisiran	1.6	mg	P
C10AX18	volanesorsen	20	mg	P
D11AH07	tralokinumab	16.1	mg	P
D11AH08	abrocitinib	0.15	g	O
G01AF21	tinidazole	0.2	g	V
J01GB06	amikacin	0.59	g	Inhal.solution
J05AB18	molnupiravir	1.6	g	O
J05AE30	nirmatrelvir and ritonavir	0.6 ¹⁾	g	O
J06BD05	sotrovimab	0.5	g	P
L04AA45	filgotinib	0.2	g	O
L04AA50	ponesimod	20	mg	O
L04AA52	ofatumumab	0.67	mg	P
L04AA59	avacopan	60	mg	O
L04AC21	bimekizumab	5.7	mg	P
L04AX09	diroximel fumarate	0.924	g	O
M05BX05	burosumab	2.5	mg	P
M05BX06	romosozumab	7	mg	P
M09AX10	risdiplam	5	mg	O
N02CD06	rimegepant	37.5	mg	O
N03AX26	fenfluramine	8	mg	O
N07BC01	buprenorphine	1.6	mg	implant
N07XX15	inotersen	41	mg	P
P01CX04	miltefosine	0.15	g	O

1) refers to nirmatrelvir

Last updated: 2022-11-25